Tier 2 — strong

Short-Term Oral Quercetin Supplementation Improves Post-exercise Insulin Sensitivity, Antioxidant Capacity and Enhances Subsequent Cycling Time to Exhaustion in Healthy Adults: A Pilot Study

Jung-Piao Tsao, Jeffrey R Bernard, Hsiu-Chen Hsu, Chin-Lin Hsu, Su-Fen Liao, I-Shiung Cheng
Frontiers in nutrition 2022 9:875319

Bibliography

PubMed
PMID 35571883
PubMed Central
PMC9096901
Funding
Funding was not specified in the indexed record or the disclosure metadata available for this entry.
Competing interests
Reported disclosure: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor MK declared a past collaboration with the authors S-FL, I-SC, and J-PT at the time of review.

Study snapshot

DesignRandomized single-blind placebo-controlled crossover exercise pilot
ModelHuman intervention research
Sample12 healthy physically active adults
InterventionQuercetin 1,000 mg/day or placebo
Duration7 days per condition
EndpointsGlucose and insulin measures; Oxidative-stress measures; Exercise performance or recovery

What the study showed, in plain terms

Published in 2022, this source examined exercise and recovery. Design: Randomized single-blind placebo-controlled crossover exercise pilot. Sample/model: 12 healthy physically active adults. The exposure or intervention was Quercetin 1,000 mg/day or placebo. Follow-up or treatment period: 7 days per condition.

Cycling time to exhaustion and selected post-exercise insulin, antioxidant, and recovery measures improved; several other outcomes did not.

Very small, short, single-blind study with multiple endpoints. Mixed results do not establish a consistent performance or metabolic benefit.

Continue with Quercetin Data Center

For topic-level interpretation, read Quercetin for Exercise: Performance, Recovery and Muscle. This is a related guide; the citation panel separately identifies articles that directly cite this paper.

Key findings

  • Cycling time to exhaustion and selected post-exercise insulin, antioxidant, and recovery measures improved; several other outcomes did not.
  • The recorded outcome domains were Glucose and insulin measures; Oxidative-stress measures; Exercise performance or recovery.
  • The result applies to the tested exposure: Quercetin 1,000 mg/day or placebo; 7 days per condition.

What this study can and cannot tell us

  • Very small, short, single-blind study with multiple endpoints. Mixed results do not establish a consistent performance or metabolic benefit.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Source check: PubMed abstract and indexed metadata; full methods were not independently confirmed for this entry. Missing method details, funding information or participant denominators are not inferred.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified